Company intelligence / Profile preview
Bosnalijek
Sarajevo*, Bosnia & Herzegovinabosnalijek.ba ↗
- Ownership
- Private
- Employees
- ~720
- Development stage
- Commercial
01
Overview
Bosnalijek is the largest pharmaceutical company in Bosnia and Herzegovina with a commercial portfolio of over 160 drugs across major therapeutic areas. The company focuses on mass-market therapeutics for oral, parenteral and topical administration. Its products are widely available in Central/South-Eastern Europe and CIS countries. Key brands such as Lysobact® and Enterofuryl® are top sellers in their categories in Russia. No proprietary clinical-stage NCEs or biologics reported.
- Therapeutic areas
- GastroenterologyPulmonologyCardiovascularDermatologyOtherNeurologyInfectious Diseases
- Modalities
- Small molecules (primarily generics and branded generics)dietary supplementsdisinfectants
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
No major global pharma partnerships disclosed; IFC provided financing for expansion projects.
Beyond the preview
Go deeper on Bosnalijek.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bosnalijek.